Potent P2Y12 Inhibitor Therapy for All?

被引：0
|
作者：
Brown, Oliver I. [1 ]
Rossington, Jennifer A. [1 ]
Hoye, Angela [1 ]
机构：
[1] Univ Hull, Hull York Med Sch, Castle Hill Hosp, Dept Acad Cardiol, Castle Rd,Daisy Bldg, Kingston Upon Hull HU16 5JQ, East Yorkshire, England
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 70卷 / 11期
关键词：
ACUTE CORONARY SYNDROME; CLOPIDOGREL; TICAGRELOR; JAPANESE; PHILO;
D O I：
10.1016/j.jacc.2017.05.079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1425 / 1425
页数：1
相关论文
共 50 条
  • [1] P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitor
    Kim, Juwon
    Jang, Woo Jin
    Lee, Wang Soo
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Choi, Jin-Ho
    Bin Song, Young
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Lee, Sang Hoon
    Oh, Ju-Hyeon
    Chun, Woo Jung
    Park, Yong Hwan
    Im, Eul-Soon
    Jeong, Jin-Ok
    Cho, Byung Ryul
    Oh, Seok Kyu
    Yun, Kyeong Ho
    Cho, Deok-Kyu
    Lee, Jong-Young
    Koh, Young-Youp
    Bae, Jang-Whan
    Choi, Jae Woong
    Yoon, Hyuck Jun
    Lee, Seung Uk
    Cho, Jang Hyun
    Choi, Woong Gil
    Rha, Seung-Woon
    Hahn, Joo-Yong
    HEART, 2021, 107 (13) : 1077 - 1083
  • [2] Is P2Y12 inhibitor therapy associated with an increased risk of cancer?
    Kaufmann, Christoph C.
    Lyon, Alexander R.
    Wojta, Johann
    Huber, Kurt
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2019, 5 (02) : 100 - 104
  • [3] Dual Therapy (P2Y12
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2019, 8 (04) : 256 - 256
  • [4] Potent P2Y12 Inhibitors and Bleeding Complications
    Guner, Ahmet
    Guner, Ezgi Gultekin
    Kahraman, Serkan
    Uzun, Fatih
    Erturk, Mehmet
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2022, 50 (07): : 543 - 544
  • [5] Strategies to optimize initial P2Y12 inhibitor therapy in STEMI patients
    Millhuff, Alexandra C.
    Blankenship, James C.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2025, 71 : 43 - 49
  • [6] P2Y12 Inhibitor Monotherapy vs. Dual Antiplatelet Therapy
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1156 - 1156
  • [7] Factors Influencing Provider and Patient Choice of P2Y12 Inhibitor Therapy
    Benitez, Rebekah M.
    Lusk, Kathleen A.
    Ahmed, S. Hinan
    Hartzell, Stephanie A.
    Kalich, Bethany A.
    JOURNAL OF PHARMACY PRACTICE, 2022, 35 (02) : 235 - 243
  • [8] Guided P2Y12 inhibitor therapy after percutaneous coronary intervention
    Sibbing, Dirk
    Kastrati, Adnan
    LANCET, 2021, 397 (10283): : 1423 - 1425
  • [9] Risk stratification for ischemic and bleeding events in patients using a potent P2Y12 inhibitor
    Park, Y. W.
    Jeong, Y. H.
    Hwang, J. Y.
    Kwack, C. H.
    Hwang, S. J.
    EUROPEAN HEART JOURNAL, 2018, 39 : 347 - 347
  • [10] P2Y12 inhibitor in acute coronary syndromes
    Wiwanitkit, Viroj
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (04): : 249 - 249
12345